EUVIMEDEUVIMED entdecken
Crossref

Real-life evaluation of hypersensitive I-troponin on a point-of care analyser in an emergency unit

Léo Mottin, Iliasse Idrissi Kassimy, Hélène Girot, Romain Leguillon, Luc Marie Joly, Valery Brunel

Annales de Biologie Clinique · 2023

DOI: 10.1684/abc.2023.1804 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annales de Biologie Clinique, 2023. Verfasst von Léo Mottin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Service de Biochimie Générale, Institut du Biologie Clinique, CHU de Rouen, 1 rue de Germont, 76031 Rouen cedex. Hauptthemen laut MEDLINE: Troponin T, Acute Coronary Syndrome.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

European Society of Cardiology (ESC) guidelines allow to perform rapid rule-in and rule-out algorithm with rapid troponin kinetics for the management of suspected Non ST-elevation acute coronary syndrome. These recommendations allow the use of point-of-care testing (POCT) systems provided that they have sufficient analytical performance. The aim of our study was to evaluate in real life the feasibility and performance of using a high sensitivity cardiac troponin I POCT system assay (hs-cTnI, Atellica® VTLi, Siemens) compared to high sensitivity cardiac troponin T values (hs-cTnT, e602®, Roche) obtained for patients admitted to emergency department. Analytical verification showed a coefficient of variation below 10% for hs-cTnI. Comparison of both troponins was moderate (r = 0.7). The study included 117 patients with a median age of 65 years, 30% had renal failure and 36% presented with chest pain. In this study, the hs-cTnT value was, more often, higher than the 99th percentile than the hs-cTnl value, even for an age-adjusted 99th percentile hs-cTnT value. The concordance of the results was moderate (Cohen's Kappa: 0.54), age remaining the most important explanatory value of discordance. Only hs-cTnT had a predictive value for hospitalization. We did not observe any interpretation discrepancies for patients who had troponin kinetics. This study confirms the feasibility of using a POCT analyzer in the emergency department, provided that it performs high sensitivity troponin. However, some data are missing to be able to use it in the framework of rapid algorithm. Finally, the implementation of POCT requires collaboration between biologists and emergency physicians in terms of organization and interpretation of values, for the overall benefit of the patient.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Troponin TAcute Coronary SyndromeHumansAgedTroponin IPoint-of-Care SystemsEmergency Service, HospitalBiomarkers

Stichwörter der Autor:innen

I troponinT troponinemergencypoint of carethoracic pain

Substanzen

Troponin TTroponin IBiomarkers

Autor:innen und Institutionen

  • Service de Biochimie Générale, Institut du Biologie Clinique, CHU de Rouen, 1 rue de Germont, 76031 Rouen cedex.
  • Service des Urgences, CHU de Rouen, 1 rue de Germont, 76031 Rouen cedex.
  • Département d'Information et d'Informatique, CHU de Rouen, 1 rue de Germont 76031 Rouen cedex.

Zitieren

APA

Mottin, L., Kassimy, I. I., Girot, H., Leguillon, R., Joly, L. M., & Brunel, V. (2023). Real-life evaluation of hypersensitive I-troponin on a point-of care analyser in an emergency unit. Annales de Biologie Clinique. https://doi.org/10.1684/abc.2023.1804

Vancouver

Mottin L, Kassimy II, Girot H, Leguillon R, Joly LM, Brunel V. Real-life evaluation of hypersensitive I-troponin on a point-of care analyser in an emergency unit. Annales de Biologie Clinique. 2023. doi:10.1684/abc.2023.1804

BibTeX
@article{Mottin2023,
  author = {Mottin, Léo and Kassimy, Iliasse Idrissi and Girot, Hélène and Leguillon, Romain and Joly, Luc Marie and Brunel, Valery},
  title = {Real-life evaluation of hypersensitive I-troponin on a point-of care analyser in an emergency unit},
  journal = {Annales de Biologie Clinique},
  year = {2023},
  doi = {10.1684/abc.2023.1804}
}
Kostenlos starten →